Farnesene

Other Names

(3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene(3E,6E)-a-Farnesene(3E,6E)-alpha-Farnesene(3E,6E)-α-Farnesene(6E)-7,11-Dimethyl-3-methylene-1,6,10-dodecatriene(6E)-7,11-Dimethyl-3-methylenedodeca-1,6,10-triene(6E)-7,11-Dimethyl-3-methylidenedodeca-1,6,10-triene(6Z)-7,11-Dimethyl-3-methylene-1,6,10-dodecatriene(E)-7,11-Dimethyl-3-methylene-1,6,10-dodecatriene(E)-7,11-Dimethyl-3-methylenedodeca-1,6,10-triene(E)-α-Farnesene(E)-β-Farnesene(E,E)-alpha-Farnesene(E,E)-α-Farnesene(E,Z)-α-Farnesene(Z)-β-Farnesene(Z,E)-α-Farnesene(Z,Z)-α-Farnesene1,3,6,10-Dodecatetraene, 3,7,11-trimethyl-1,3,6,10-Dodecatetraene, 3,7,11-trimethyl-, (3E,6E)-1,3,6,10-Dodecatetraene, 3,7,11-trimethyl-, (E,E)-1,6,10-Dodecatriene, 7,11-dimethyl-3-methylene-1,6,10-Dodecatriene, 7,11-dimethyl-3-methylene-, (6E)-1,6,10-Dodecatriene, 7,11-dimethyl-3-methylene-, (6Z)-1,6,10-Dodecatriene, 7,11-dimethyl-3-methylene-, (E)-3,7,11-Trimethyl-(E,E)-1,3,6,10-Dodecatetraene3,7,11-Trimethyl-1,3,6,10-dodecatetraene3,7,11-Trimethyldodeca-1,3,6,10-tetraene7,11-Dimethyl-3-methylene-1,6,10-dodecatriene7,11-Dimethyl-3-methylenedodeca-1,6,10-triene7,11-Dimethyl-3-methylidenedodeca-1,6,10-trienea-Farnesenealpha-Farnesenebeta-FarneseneFarnesene (mixture of isomers)FEMA 3839trans,trans-a-Farnesenetrans-a-Farnesenetrans-alpha-Farnesenetrans-β-Farneseneα-Farneseneβ-Farnesene

Synopsis

Farnesene: A Comprehensive Reference

1. Identity: Names, Chemistry, and Natural Sources

1.1 Nomenclature and Chemical Identity

The term farnesene refers to a set of six closely related chemical compounds, all of which are sesquiterpenes. They are compounds containing three isoprene units, which have 15 carbons and 24 hydrogens per molecule (C₁₅H₂₄). The two most biologically and commercially significant forms are α-farnesene (alpha-farnesene) and β-farnesene (beta-farnesene), each of which exists as multiple stereoisomers.

The principal naturally occurring form is (E,E)-α-farnesene (CAS 502-61-4), also known by the systematic IUPAC name (3E,6E)-3,7,11-trimethyldodeca-1,3,6,10-tetraene. This disorder involves both the accumulation and oxidation of the sesquiterpene α-farnesene ([3E,6E]-3,7,11-trimethyl-1,3,6,10-dodecatetraene). Another stereoisomer, (Z,E)-α-farnesene (CAS 26560-14-5), has been isolated from the oil of perilla. β-Farnesene has one naturally occurring isomer; the E isomer is a constituent of various essential oils.

Farnesene is one of the simplest acyclic sesquiterpenes, meaning its carbon skeleton is unbranched and contains no rings. Farnesene is a sesquiterpene, which is part of a larger class of compound called terpenes. Terpenes include hemiterpenes, monoterpenes, sesquiterpenes, diterpenes, sesterterpenes, triterpenes, tetraterpenes, and polyterpenes.

1.2 Natural Sources

Farnesene is widely distributed in the plant kingdom and across diverse taxonomic families:

Apple (Malus domestica): In plants, farnesene can be found as a natural coating on fruits such as apples, and as a major component of different essential oils. The α-farnesene isomer is a particularly significant component of the epicuticular wax of apple fruit. The skin browning seen in superficial scald is caused by the oxidation of α-farnesene, a volatile compound naturally produced by the apple; this compound accumulates in the wax layer during the first 8–12 weeks of cold storage.
Chamomile (Matricaria chamomilla, German chamomile; Chamaemelum nobile, Roman chamomile): Farnesene is often found in chamomile and rose and many other floral essential oils. In a Nepalese chemotype, the major components of chamomile oil were (E)-β-farnesene (42.2%), α-bisabolol oxide A (22.3%), (E,E)-α-farnesene (8.3%), cis-bicycloether (5.0%), α-bisabolol oxide B (4.5%), and α-bisabolone oxide A (4.0%). This Nepalese oil represents a chemically distinct chemotype. A cluster analysis based on the chemical compositions of 48 samples of chamomile oil reported in the literature has revealed seven chemotypes, and the oil from Nepal represents the (E)-β-farnesene chemotype.
Ginger (Zingiber officinale): Among more than 200 identified compounds in ginger, its bioactive constituents include terpenes such as α-zingiberene, β-bisabolene, β-sesquiphellandrene, ar-curcumene, and (E,E)-α-farnesene. The sesquiterpenes zingiberene, alpha-curcumene, bisabolone, and farnesene dominate ginger essential oil.
Artemisia species (sagebrush, tarragon, wormwood): Farnesene is a unique component of Artemisia dracunculus (tarragon), and has been demonstrated to inhibit human neutrophil activation and chemotaxis.
Perilla (Perilla frutescens): (Z,E)-α-Farnesene has been isolated from the oil of perilla.
Conifers and Euphorbia (spurge) species: Suitable conifer sources include cedars, cypresses, Douglas-firs, firs, junipers, kauris, larches, pines, redwoods, spruces, and yews. Spurges (Euphorbia) are a very diverse worldwide genus of plants belonging to the spurge family (Euphorbiaceae), consisting of about 2,160 species and comprising one of the largest genera in the plant kingdom.
Aphids (insect source): Farnesene is a branched-chain sesquiterpene naturally produced by aphids as an alarm pheromone. It is also released by aphids as an alarm pheromone upon death to warn away other aphids.
Cedrelopsis grevei (katrafay): A study of this Malagasy species found the major constituent of the leaves essential oil was (E)-β-farnesene (27.61%).

1.3 Common Forms and Preparations

Farnesene is encountered in several forms relevant to commercial and research contexts:

Volatile essential oils: Extracted from plant material (flowers, leaves, rhizomes) by steam distillation or hydrodistillation, in which farnesene is a constituent component alongside other terpenes and volatile compounds. The active constituents of chamomile are mainly present in fresh or dried flower; therefore, infusions or essential oils are used in medicinal preparations.
Isolated pure sesquiterpene: Farnesene can be isolated or derived from terpene oils. A chemical synthetic method includes dehydrating nerolidol with phosphoryl chloride in pyridine.
Bio-fermentation-derived farnesene: Natural sources of farnesene are limited by plant growth and strict environmental conditions and are unable to meet the growing market demand; to realize sustainable production, heterologous microbial hosts such as E. coli and Saccharomyces cerevisiae have been employed.
Cosmetic and fragrance preparations: Farnesene exists in α and β forms and plays a key role as a specialty feedstock for different chemical transformations to produce a wide variety of commodity products, ranging from cosmetic oils and lubricants to fuels.

2. Traditional and Historical Use

2.1 Use via Chamomile-Containing Preparations

Farnesene has not historically been isolated as a single compound; rather, it has been consumed or applied as part of complex botanical preparations — most prominently those derived from chamomile and ginger — in which it is a constituent terpene. The medicinal history of these plants, and by extension of farnesene as an active component, spans millennia and multiple cultures.

Chamomile has a long history of traditional medicinal uses. Chamomile preparations have been commonly used for many human ailments such as hay fever, inflammation, muscle spasms, menstrual disorders, insomnia, ulcers, wounds, gastrointestinal disorders, rheumatic pain, and hemorrhoids. Many different preparations of chamomile have been developed, the most popular of which is in the form of herbal tea, consumed more than one million cups per day.

In ancient Greek and Roman civilization, chamomile was highly prized for its calming and soothing properties; it was used in baths to relieve tired muscles and was commonly brewed as a tea to help with digestion and nervous tension. The Romans used chamomile as a wound healer, employing it in poultices for bruises and inflammation. In Ayurvedic medicine, chamomile has been used for thousands of years for its ability to cool the body and calm the mind, and was frequently employed in digestive care. The pharmacological context of these traditional uses is attributed in part to farnesene: essential oils containing farnesene were used in the past for the same purposes that aspirin and ibuprofen are used today, given their significant anti-inflammatory and antiallergy properties.

Components present in chamomile essential oil — chamazulene, α-bisabolol, and cis-β-farnesene — are hydrophobic in nature, forming part of the active phytochemical matrix responsible for the plant's therapeutic reputation.

2.2 Use via Ginger-Containing Preparations

Ginger (Zingiber officinale), in which farnesene is a constituent sesquiterpene, has an extensive cross-cultural medicinal history. In Ayurveda, the ancient system of medicine in India, ginger has been referred to as "the universal medicine"; practitioners used ginger oil and root preparations to treat stomach discomfort, colds, and fatigue, and its warming qualities were believed to ignite the "digestive fire," promoting energy and vitality.

2.3 Use via Artemisia Species

Species of Artemisia, including tarragon (A. dracunculus), have been employed in traditional herbal medicine across European, North American Indigenous, and Central Asian healing systems. The immunomodulatory properties attributed to tarragon essential oil, now partly linked to its farnesene content, reflect a pattern of traditional use for inflammatory and febrile complaints. Essential oils, a volatile mixture derived from plants, have shown a wide biological activity and have been used as ancient remedies for the treatment of various diseases.

3. Biosynthesis and Active Constituents

3.1 Biosynthetic Origin: The Mevalonate and Isoprenoid Pathway

Farnesene is biosynthesized in plants through the cytosolic mevalonate (MVA) pathway, the primary route to sesquiterpene formation. In the human body, the mevalonate pathway is responsible for the biosynthesis of all isoprenoids, which consist of a vast array of metabolites vital for proper cellular functions. In plants, the same pathway serves as the foundation for sesquiterpene production. Farnesyl pyrophosphate (FPP) is derived from mevalonate, serving as the branching point for the non-steroid isoprenoid pathway and the sterol synthesis pathway.

The first branching point of the mevalonate pathway is occupied by farnesyl pyrophosphate synthase (FPPS), the enzyme responsible for the catalytic elongation of DMAPP first to geranyl pyrophosphate (GPP) and then to FPP via the successive condensation of two IPP units. FPP is subsequently converted into a wide range of other natural products, including volatile sesquiterpenes such as β-farnesene and α-bergamotene. In apple tissue specifically, biosynthesis of α-farnesene occurs through the isoprenoid pathway, and the conversion of FPP to α-farnesene is catalyzed by a single sesquiterpene synthase enzyme, trans,trans-α-farnesene synthase, rather than via farnesol as an intermediate.

In apple fruit, the production of α-farnesene is tightly coupled to ripening and ethylene signaling. The concentration of α-farnesene rises as the fruit ripens, tracking ethylene production; it is then oxidized by atmospheric oxygen. The etiology of superficial scald has long been associated with the biochemistry of the acyclic sesquiterpene α-farnesene, a volatile organic compound specifically accumulated during ripening in the waxy layer of the fruit cuticle, exclusively synthesized via the cytosolic mevalonic acid pathway.

3.2 Relationship to Farnesol

Farnesene is chemically distinct from farnesol, its closely related sesquiterpene alcohol (C₁₅H₂₆O). Farnesol is the direct alcoholic derivative of farnesene and shares the same carbon skeleton. Farnesol, as an alcoholic derivative of farnesene, has been foreseen as a commercial diesel fuel alternative. Much of the pharmacological literature — particularly that pertaining to antifungal, antimicrobial, and anticancer effects — concerns farnesol rather than farnesene itself. This distinction is critical for evaluating health claims; the two molecules, while related, have different biochemical profiles and should not be conflated.

4. Key Biological Activities and Mechanisms of Action

4.1 Anti-Inflammatory Activity

The most extensively studied biological activity of farnesene is its anti-inflammatory potential, investigated primarily through cell-based and animal models.

A 2022 study published in Pharmaceuticals (PMC9143003) investigated the immunomodulatory effects of farnesene isolated from Artemisia dracunculus essential oils on human neutrophils. Although Artemisia essential oils were weak activators of human neutrophils, they were relatively more potent in inhibiting subsequent neutrophil Ca²⁺ mobilization with the N-formyl peptide receptor 1 (FPR1) agonist fMLF and FPR2 agonist WKYMVM, with the most potent being essential oils from A. dracunculus. Farnesene, a unique component of A. dracunculus, inhibited human neutrophil activation and chemotaxis and is likely one of the main active components; based on the critical role of neutrophils in inflammation, these data support the possibility that farnesene could have the potential for the development of new anti-inflammatory agents.

Farnesene has significant anti-inflammatory and antiallergy properties, and in the past essential oils containing farnesene were used for the same purposes that aspirin and ibuprofen are used today. This comparison is drawn in the context of the traditional pharmacological use of chamomile and similar essential-oil-bearing plants.

Evidence strength: The mechanistic anti-inflammatory evidence for isolated farnesene consists of one notable cell-based study on human neutrophils, plus broader literature on chamomile essential oil fractions. There are no large-scale randomized clinical trials examining anti-inflammatory outcomes attributable specifically to farnesene as an isolated compound.

4.2 Antioxidant Activity

Farnesene (FNS) is an acyclic sesquiterpene that has a wide range of important biological effects such as antioxidant, antimicrobial, and antifungal properties. An in vitro study examining the oxidative effects of farnesene on human blood cells found that in vitro treatments with farnesene led to increases of total antioxidant capacity (TAC) levels in cultured blood cells without changing total oxidative stress (TOS) levels as compared to the control group, suggesting a net antioxidant effect at sub-cytotoxic concentrations.

Evidence strength: Antioxidant findings are preliminary and confined to in vitro cell culture systems. No clinical human trials have measured antioxidant outcomes attributable to farnesene as an isolated compound.

4.3 Antimicrobial Activity

Chamomile essential oil dominated by β-farnesene has been screened for antimicrobial activity. The chamomile oil from Nepal was screened for antimicrobial activity against Bacillus cereus, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Aspergillus niger. A β-farnesene-dominant chemotype of chamomile has also been characterized for a broad panel of bioactivities: a 2015 study focusing on the composition of a β-farnesene-dominant chemotype of chamomile found that "it has been found to show antimicrobial, anti-inflammatory, antioxidant, antispasmodic, antiviral and sedative activities."

The essential oil of Cedrelopsis grevei, where the major constituent was (E)-β-farnesene (27.61%), was tested for cytotoxic activity against human breast cancer cells MCF-7 and antimalarial activity against Plasmodium falciparum; the oil was active against MCF-7 cell lines (IC₅₀ = 21.5 mg/L) and against P. falciparum (IC₅₀ = 17.5 mg/L). However, the major constituent being β-farnesene does not definitively assign these activities to farnesene alone.

Note on farnesol vs. farnesene: The bulk of the published antimicrobial and antifungal literature in indexed databases relates specifically to farnesol (the alcohol derivative), not farnesene itself. These two molecules should not be conflated. No rigorous human clinical trials on the antimicrobial effects of isolated farnesene have been identified.

4.4 Insect Semiochemical Activity

Farnesene's most thoroughly established biological roles at the molecular level are ecological rather than pharmacological. Both the (E,E) and (Z,E)-α-farnesene isomers are known insect semiochemicals; they act as alarm pheromones in termites or food attractants for the apple tree pest, the codling moth. β-Farnesene is released by aphids as an alarm pheromone upon death to warn away other aphids, and several plants, including potato species, have been shown to synthesize this pheromone as a natural insect repellent. E-beta-farnesene shows biological activity in at least ten aphid species, making this the most interspecially active pheromone known.

4.5 Sedative and Anxiolytic Properties

The sedative and calming properties traditionally attributed to chamomile are thought to involve multiple components of the essential oil including farnesene. Farnesene is a less-discussed but significant sesquiterpene found in German chamomile that contributes to the oil's soothing, antispasmodic, and calming properties and also offers mild antimicrobial effects. The proposed mechanism includes modulation of the nervous system, though the specific molecular target for farnesene's sedative activity in humans has not been established in the published clinical literature.

4.6 Relationship of α-Farnesene to Apple Storage and Oxidative Stress

In postharvest science, α-farnesene in apple wax represents a well-studied phytochemical phenomenon. Conjugated triene oxidation products of the sesquiterpene α-farnesene, implicated as causal agents of the storage disorder superficial scald, were extracted from apple skin wax. α-Farnesene can be downstream-oxidized to conjugated trienols (CTols) and further to 6-methyl-5-hepten-2-one (MHO), and it is these oxidation products — not farnesene itself — that are believed to cause cellular damage in the fruit peel. This mechanistic insight has prompted research into antioxidant-based postharvest strategies.

5. Scientific Evidence by Area of Use

5.1 Inflammation and Immune Modulation

Best available study: A 2022 study (Schepetkin et al., Pharmaceuticals 15(5):642; PMC9143003) isolated essential oils from five Artemisia species and characterized their chemical compositions and innate immunomodulatory activities. The study characterized the chemical composition and immunomodulatory activity of flower and leaf essential oils from five Artemisia species collected in Montana; several of the essential oils potently inhibited intracellular Ca²⁺ mobilization in human neutrophils, with the most active being essential oils from A. dracunculus. The researchers then isolated farnesene as a unique component of A. dracunculus and tested it independently. Farnesene, a unique component of A. dracunculus, inhibited human neutrophil activation and chemotaxis and is likely one of the main active components.

Limitation: This is a cell-based (in vitro) study using isolated human neutrophils; it does not constitute a clinical trial. No dose-response relationship in a human inflammatory disease model has been established for farnesene as a single isolated compound.

5.2 Antioxidant Effects

Key study: A study examining the cytotoxic, genotoxic, and oxidative effects of farnesene in human blood cells (published in ResearchGate/indexed database) used MTT and LDH assays for cytotoxicity and total antioxidant capacity (TAC) / total oxidative stress (TOS) parameters for oxidative changes. The results revealed that farnesene reduced cell viability at concentrations of higher than 100 µg/mL. All tested concentrations of farnesene were found to be non-genotoxic. In vitro treatments with farnesene led to increases of TAC levels in cultured blood cells without changing TOS levels as compared to the control group.

Limitation: These are in vitro findings only. The cytotoxic threshold (above 100 µg/mL) is an important safety consideration for any potential therapeutic formulation. No clinical oxidative-stress trials using farnesene have been conducted.

5.3 Antimicrobial Effects (Essential Oils Containing Farnesene)

Studies on chamomile essential oil dominated by β-farnesene have shown activity against a range of microbial species, but isolating farnesene's individual contribution from other constituents (bisabolol, chamazulene, etc.) is methodologically challenging. The β-farnesene-dominant Nepalese chamomile oil was screened for antimicrobial activity against Bacillus cereus, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Aspergillus niger. These studies evaluated the whole oil, not isolated farnesene.

Limitation: No study has rigorously attributed specific minimum inhibitory concentrations (MICs) to isolated farnesene (the hydrocarbon) against human pathogens in a validated clinical context. The much larger body of antimicrobial research concerns farnesol, a structurally related but pharmacologically distinct molecule.

5.4 Cytotoxic / Potential Anticancer Effects

Evidence on farnesene's direct anticancer potential is very limited and preliminary. The β-farnesene-dominant essential oil of Cedrelopsis grevei showed cytotoxic activity against MCF-7 breast cancer cells in vitro, with the essential oil active against MCF-7 cell lines (IC₅₀ = 21.5 mg/L). However, the multicomponent nature of the essential oil means these effects cannot be attributed solely to farnesene.

Important distinction: Several peer-reviewed papers describe anticancer effects of farnesol (PMC10750447, PubMed 23923645), not farnesene. Farnesol has been shown to regulate tumorigenic proteins and signal transduction cascades. These findings should not be extrapolated to farnesene without direct experimental evidence.

Evidence strength for farnesene: Entirely preliminary; in vitro and in complex mixtures only. No clinical evidence.

5.5 Apple Postharvest Physiology (Non-Therapeutic)

This is the most robustly studied area involving farnesene, though not in the context of human health supplementation. The etiology of superficial scald has long been associated with the biochemistry of the acyclic sesquiterpene α-farnesene, a volatile organic compound specifically accumulated during ripening in the waxy layer of the fruit cuticle, exclusively synthesized via the cytosolic mevalonic acid pathway. Ultra-low oxygen storage is effective in reducing the oxidation of α-farnesene by severely restricting the oxygen in the storage atmosphere. These postharvest findings are well-established horticultural science, distinct from dietary supplement or therapeutic applications.

6. Body Systems and Health Areas of Association

6.1 Immune and Inflammatory System

The most experimentally supported association is with modulation of the innate immune system. Farnesene, as demonstrated in the A. dracunculus study, can directly inhibit neutrophil activation and chemotaxis. Based on the critical role of neutrophils in inflammation, the data support the possibility that farnesene could have the potential for the development of new anti-inflammatory agents.

6.2 Gastrointestinal System

Chamomile preparations containing farnesene, historically administered as teas or infusions, have been used for gastrointestinal complaints. Chamomile preparations have been commonly used for gastrointestinal disorders including ulcers, spasms, and inflammatory conditions of the gut. A 2015 study on the β-farnesene-dominant chamomile chemotype found that it "has been found to show antimicrobial, anti-inflammatory, antioxidant, antispasmodic, antiviral and sedative activities" and is also used as a treatment against sore stomach and irritable bowel syndrome. These claims derive from the use of the whole essential oil, not isolated farnesene; their applicability to supplemental farnesene as a single compound is unknown.

6.3 Nervous System

Chamomile preparations have been commonly used for insomnia. Chamomile (M. chamomilla L.) is an herbaceous plant that has a long history of use in traditional medicine and has been used as a herbal remedy for thousands of years to treat several diseases, including neuropsychiatric disorders. The specific contribution of farnesene to sedative or anxiolytic effects — as opposed to other chamomile constituents such as apigenin — has not been elucidated in controlled clinical trials.

6.4 Skin and Dermatology

Farnesene is encountered in cosmetic and skincare preparations as a component of essential oils. Its antioxidant and anti-inflammatory properties have been cited as relevant to skin health. Farnesene's wide range of biological effects includes antioxidant, antimicrobial, and antifungal properties that are of interest to formulators. However, no controlled human trials have examined dermatological outcomes for farnesene specifically.

7. Dosage Forms and Reported Dosages

There is no established standardized therapeutic dose for farnesene as an isolated dietary supplement. The compound is encountered in two primary dosage contexts in the literature:

In vitro research concentrations: Farnesene reduced cell viability at concentrations of higher than 100 µg/mL in human blood cell cultures, establishing a threshold above which cytotoxic effects were observed.
As a component of essential oil preparations: Farnesene is consumed as part of essential oils derived from chamomile, ginger, and related plants. The active constituents are mainly present in fresh or dried flower; therefore, infusions or essential oils are used in medicinal preparations. The flower yields a maximum of 2% of volatile oil, which houses more than 120 constituents. The concentration of farnesene within these preparations varies by chemotype, geographic origin, and extraction method.
Artemisia dracunculus immunomodulatory study: In the 2022 study (Schepetkin et al.), farnesene was characterized for its inhibitory effects on human neutrophil Ca²⁺ mobilization as an isolated compound at experimental concentrations. The exact concentrations used are stated in the full publication but are experimental, not clinical dosages.

No human clinical trial has established a safe or effective supplemental dose for isolated farnesene. No pharmacopoeia monograph (European Pharmacopoeia, USP, WHO) specific to farnesene as a standalone supplement has been identified.

8. Safety Considerations

8.1 Cytotoxicity at High Concentrations

Farnesene reduced cell viability at concentrations of higher than 100 µg/mL in human blood cell assays, indicating that elevated doses produce cytotoxic effects in vitro. All tested concentrations of farnesene were found to be non-genotoxic, and in vitro treatments with farnesene led to increases of TAC levels in cultured blood cells without changing TOS levels, suggesting that at sub-cytotoxic doses, oxidative damage is not induced.

8.2 Aspiration Hazard (Pure Liquid Form)

Industry safety data for farnesene as a pure chemical indicate an aspiration hazard: it may be fatal if swallowed and enters airways. This hazard is associated with the liquid hydrocarbon form and is relevant to occupational and industrial handling. Farnesene causes mild skin irritation and is not expected to cause skin sensitization. The product is not expected to cause reproductive or developmental effects.

8.3 Genotoxicity

The mutagenic activity of β-farnesene has been evaluated in a bacterial reverse mutation assay conducted in compliance with GLP regulations, and based on that assessment, β-farnesene does not present a concern for genotoxic potential. This finding is consistent with the in vitro study reporting that all tested concentrations of farnesene were found to be non-genotoxic.

8.4 Carcinogenicity

Farnesene is not listed in the IARC Monographs for overall evaluation of carcinogenicity. It is not listed in the US National Toxicology Program (NTP) Report on Carcinogens.

8.5 Regulatory and Classification Status

Farnesene as a fragrance and flavoring ingredient is covered by FEMA GRAS guidelines in the United States. Farnesene falls under FEMA GRAS/FDA guidelines. This designation applies to its use as a flavoring/fragrance agent; it does not constitute approval of therapeutic or supplemental health claims.

The closely related compound farnesol (distinct from farnesene) has been formally reviewed by the IFRA and found to be a weak skin sensitizer. Because farnesene is structurally related, practitioners and formulators in the cosmetic sector should be aware of potential cross-reactivity, though direct evidence for farnesene as a sensitizer was not found in identified sources.

8.6 Evidence Gaps and Research Limitations

The overall evidence base for farnesene as a dietary supplement or standalone therapeutic agent is thin. The majority of existing research involves:

Complex essential oil mixtures in which farnesene is one of many constituents, making it impossible to attribute observed effects to farnesene alone.
In vitro cell culture studies, which do not reliably predict therapeutic outcomes in humans.
Conflation with farnesol, a structurally related but pharmacologically distinct compound, in some popular literature.
Absence of human pharmacokinetic data (absorption, distribution, metabolism, elimination) for farnesene as an isolated compound.
No randomized controlled clinical trials for any therapeutic indication.

References

Health Conditions

Health conditions that Farnesene may help support.

No conditions available.

Body Systems

Body systems that Farnesene may help support.

No body systems available.